Skip to content
10-K

Annual Report

Luckwel Pharmaceuticals Inc.

0001493152-21-014053

← back to feed
Filed
Jun 10, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2020 · May 31, 2021 147.16M sh
Operating Cash Flow FY 2020 · Mar 31, 2019 −$622.24K
Cash And Equivalents FY 2020 · Mar 31, 2019 $25.75K
Total Liabilities FY 2020 · Mar 31, 2019 $819.09K
Total Assets FY 2020 · Mar 31, 2019 $27.27K
Sga Expense FY 2020 · Mar 31, 2019 $622.53K
Net Income FY 2020 · Mar 31, 2019 −$622.53K
Stockholders Equity FY 2020 · Mar 31, 2018 −$129.3K